Rezultati pretrage - Stephan Stilgenbauer

Response to Comment by Jonathan Weiss et al. od Eugen Tausch, Stephan Stilgenbauer

Preuzmi cijeli tekst

BIRC3 mutations in chronic lymphocytic leukemia – uncommon and unfavorable od Eugen Tausch, Stephan Stilgenbauer

Preuzmi cijeli tekst

Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia od Thorsten Zenz, Daniel Mertens, Stephan Stilgenbauer

Preuzmi cijeli tekst

Chronic lymphocytic leukemia – genomics lead the way od Daniel Mertens, Lars Bullinger, Stephan Stilgenbauer

Preuzmi cijeli tekst

First-line treatment for CLL in the era of targeted therapy od Matthew S. Davids, Stephan Stilgenbauer, Constantine S. Tam

Preuzmi cijeli tekst

From Biology to Therapy: The CLL Success Story od Deyan Y. Yosifov, Christine Wolf, Stephan Stilgenbauer, Daniel Mertens

Preuzmi cijeli tekst

repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate method od Deyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, Daniel Mertens

Preuzmi cijeli tekst

Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samples od Deyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, Daniel Mertens, Eugen Tausch

Preuzmi cijeli tekst

Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2 od Angela Schulz, Grischa Toedt, Thorsten Zenz, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert

Preuzmi cijeli tekst

The MDM2 –309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia od Thorsten Zenz, Sonja Häbe, Axel Benner, Dirk Kienle, Hartmut Döhner, Stephan Stilgenbauer

Preuzmi cijeli tekst

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics od Elias Campo, Florence Cymbalista, Paolo Ghia, Ulrich Jäger, Sarka Pospisilova, Richard Rosenquist, Anna Schuh, Stephan Stilgenbauer

Preuzmi cijeli tekst

Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice od Bola S. Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, Philipp M. Roessner, Ralph Schulz, Peter Lichter, Stephan Stilgenbauer, Martina Seiffert

Preuzmi cijeli tekst

Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia od Sebastian Faehling, Mariana Coelho, Alessia Floerchinger, Christof Schneider, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert, Philipp M. Roessner

Preuzmi cijeli tekst

TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q od Angela Garding, Nupur Bhattacharya, Sarah Haebe, Frederike Müller, Dieter Weichenhan, Irina Idler, Katja Ickstadt, Stephan Stilgenbauer, Daniel Mertens

Preuzmi cijeli tekst

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia od Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer

Preuzmi cijeli tekst

Overall survival outcomes with first‐line continuous ibrutinib and fixed‐duration ibrutinib‐venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an... od Paolo Ghia, Loic Ysebaert, Ann Janssens, Stephan Stilgenbauer, Mohamed Fouad, Claudio A. Schioppa, José‐Ángel Hernández‐Rivas, Alessandra Tedeschi

Preuzmi cijeli tekst

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival od Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner

Preuzmi cijeli tekst

Corrigendum to “U-RT1 – A new model for Richter transformation” [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148] od Teresa Schmid, Julia Maier, Melanie Martin, Alpaslan Tasdogan, Eugen Tausch, Thomas F.E. Barth, Stephan Stilgenbauer, Johannes Bloehdorn, Peter Möller, Kevin Mellert

Preuzmi cijeli tekst

Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling od Katharina Filarsky, Angela Garding, Natalia Becker, Christine Wolf, Manuela Zucknick, Rainer Claus, Dieter Weichenhan, Christoph Plass, Hartmut Döhner, Stephan Stilgenbauer, Peter Lichter, Daniel Mertens

Preuzmi cijeli tekst

Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia od Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, Alessandra Tedeschi, Lindsey Roeker, Myriam Rodriguez‐Couso, Stephen P. Mulligan, Samir Kanaan Nabhan, Jan Rynne, Teresa López‐Fernández

Preuzmi cijeli tekst